Nurix Therapeutics Inc.

NASDAQ: NRIX
Share price (3/25/25): $12.58
Market cap (3/25/25): $955 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 11/30/24 FY 2024

ended 08/31/24 Q3

ended 05/31/24 Q2

ended 02/29/24 Q1

ended 11/30/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Automatic shelf registration

Ownership Filter

Commodore Capital LP

News Filter

Appoints Drug Development Expert Roy D. Baynes, MB.Bch., M.Med., Ph.D., to Its Board of Directors

Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update

Outlines 2025 Goals and Objectives for Advancement of Its Robust Pipeline in Cancer and Autoimmune Diseases

Presents New Positive Data From Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting

Other Events, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC